Jain, KK. Future of personalized medicine, Chapter 18. In: Textbook of Personalized Medicine. New York: Springer; 2009; 395–406.
Kim, K, Lee, J‐B. MEMS for drug delivery, Chapter 12. In: Wang, W, Soper, SA, eds. Bio‐MEMS: Technologies and Applications. Boca Raton, FL: CRC Press; 2006; 325–348.
Colombo, P, Sonvico, F, Colombo, G, Bettini, R. Novel platforms for oral drug delivery. Pharm Res 2009; 26: 601–611.
Santini, JT Jr, Richards, AC, Scheidt, RA, Cima, MJ, Langer, RS. Microchip technology in drug delivery. Ann Med 2000; 32: 377–379.
Santini, JT Jr, Cima, MJ, Langer, R. A controlled‐release microchip. Nature 1999; 397: 335–338.
Tao, SL, Desai, TA. Microfabricated drug delivery systems: from particles to pores. Adv Drug Deliv Rev 2003; 55: 315–328.
Gardner, DP. Microfabricated nanochannel implantable drug delivery devices: trends, limitations and possibilities. Exp Opin Drug Deliv 2006; 3: 479–487.
Shrivistava, S, Dash, D. Applying nanotechnology to human health. J Nanotech 2009; 2009: 1–14.
Shrivastava, S. Nanofabrication for drug delivery and tissue engineering. Digest J Nanomat 2008; 3: 257–263.
Tao, SL, Lubeleya, MW, Desai, TA. Bioadhesive poly(methyl methacrylate) microdevices for controlled drug delivery. J Con Rel 2003; 88: 215–228.
US Food and Drug Administration. Nanotechnology page. Available at: http://www.fda.gov/nanotechnology/. (Accessed February 1, 2010).
Sade, RM, American Medical Association. Radio Frequency ID Devices in Humans, CEJA Report 5‐A‐07, 2007.
Staples, M, Daniel, K, Cima, MJ, Langer, R. Application of micro‐ and nano‐electromechanical devices to drug delivery. Pharm Res 2006; 23: 847–863.
Okumu, FW, Cleland, JL. Implants and injectables. In: Rathbone, MJ, Hadgraft, J, Roberts, MS, eds. Modified Release Drug Delivery Technology. New York: Marcel Dekkar; 2003; 633–638.
US Food and Drug Administration. Office of Combination Products page. Available at: http://www.fda.gov/oc/combination/. (Accessed January 2, 2010).
Portnoy, S, Koepke, S. Obtaining FDA approval of drug/device combination products. Part I: regulatory strategy considerations for preclinical testing. PharmaNet Consulting. Available at: http://www.pharmanet‐cro.com/pdf/whitepapers/Combo_Products.pdf. (Accessed January 2, 2010).
The Personalized Medicine Coalition. Home page. Available at: http://www.personalizedmedicinecoalition.org/sciencepolicy/personalmed‐101_overview.php. (Accessed January 2, 2010).
Amgen. Future of biotechnology in healthcare, Chapter 9. In: An Introduction to Biotechnology. 2009; 31–35. Available at: http://www. amgenscholars.eu/web/guest/future‐of‐biotechnology‐in‐healthcare. (Accessed January 2, 2010).
Heller, A. Integrated medical feedback systems for drug delivery. Am Inst Chem Eng J 2005; 51: 1054–1066.
Brunetti, P, Federici, MO, Benedetti, MM. The artificial pancreas. Artif Cells Blood Substit Immobil Biotechnol 2003; 31: 127–138.
Elman, NM, Ho Duc, HL, Cima, MJ. An implantable MEMS drug delivery device for rapid delivery in ambulatory emergency care. Biomed Microdevices 2009; 11: 625–631.
Robertson, TL, Hafezi, H. Personal paramedic, US20080058772A1.
Singer, I, Edmonds, HL. Head‐up tilt testing predicts syncope during ventricular tachycardia in implantable cardioverter defibrillator patients. J Interv Cardiol 1998; 11: 205–211.
Fonarow, GC, Feliciano, Z, Boyle, NG, Knight, L, Woo, MA, et al. Improved survival in patients with nonischemic advanced heart failure and syncope treated with implantable cardioverter–defibrillator. Am J Cardiol 2000; 85: 981–985.
Cavaco, D, Adragao, P, Aguiar, C, Neves, J, Abecasis, M, et al. Syncope in implantable cardioverter—defibrillator pacemaker dependent patients. Eur Heart J 2002; 23: 665–665.
Sanchez, JM, Katsiyiannis, WT, Gage, BF, Chen, J, Faddis, MN, et al. Implantable cardioverter–defibrillator therapy improves long‐term survival in patients with unexplained syncope, cardiomyopathy, and a negative electrophysiologic study. Heart Rhythm 2005; 2: 367–373.
Moran, EG, Mont, L. Incidence of syncope after ICD implantation: low or high? Eur Heart J 2006; 27: 2481–2482.
Hu, M, Lindemann, T, Göttsche, T, Kohnle, J, Zengerle, R, et al. Discrete chemical release from a microfluidic chip. J Microelectromech Syst 2007; 16: 786–794.
Genzyme Corporation. Form 10‐K. Annual Report for the fiscal year ended December 31, 2009. Available at: http://www.genzyme.com/corp/investors/XBRL/As‐Filed_2009_GENZ_Form_10‐K.pdf. (Accessed May 1, 2010).
Genzyme website. The cost of enzyme replacement therapy. Available at: http://www.genzyme.com/commitment/patients/costof_treatment.asp. (Accessed January 2, 2010).
IMS Health. Decline in Growth of Prescription Drug Revenue is Forecast, New York: The Associated Press; Aug 9 2009.
BCC Research. Advanced Drug Delivery Systems: New Developments, New Technologies. 2009.
Madou, MJ. Fundamentals of Microfabrication. 2nd ed. Boca Raton, FL: CRC Press; 2002.
Ainslie, KM, Desai, TA. Microfabricated implants for applications in therapeutic delivery, tissue engineering, and biosensing. Lab Chip 2008; 8: 1864–1878.
Betancourt, T, Brannon‐Peppas, L. Micro‐ and nanofabrication methods in nanotechnological medical and pharmaceutical devices. Int J Nanomed 2006; 1: 483–495.
Santini, JT Jr, Cima, MJ, Langer, RS. Method for making microchip reservoir device, US20070047926A1, 2008.
Santini, JT Jr, Cima, MJ, Langer, RS. Microchip drug delivery devices, US007070590B1, 2006.
Santini, JT Jr, Cima, MJ, Langer, RS. Medical device with array of electrode‐containing reservoirs, US007070592B2, 2006.
Santini, JT Jr, Hutchinson, CE, Uhland, SA, Cima, MJ, Langer, RS, et al. Microfabricated devices for the delivery of molecules into a carrier fluid, US006537256B2, 2003.
Grayson, AR, Johnson, A, Flynn, N, Li, Y, Cima, MJ, et al. A bioMEMS review: MEMS technology for physiologically integrated devices. Proc IEEE 2004; 92: 6–21.
LaVan, DA, McGuire, T, Langer, R. Small‐scale systems for in vivo drug delivery. Nat Biotechnol 2003; 21: 1184–1191.
Tsai, H‐KA, Ma, K‐S, Wang, C, Xu, H, Wang, C, et al. Development of integrated protection for a miniaturized drug delivery system. Smart Mater Struct 2007; 16: S295–S299.
Tsai, H‐KA, Madou, M. Microfabrication of bilayer polymer actuator valves for controlled drug delivery. JALA 2007; 12: 291–295.
Gilad, P. Electronically‐controlled device for release of drugs, proteins, and other organic or inorganic chemicals, US20090216176A1, 2009.
Langereis, G, Iordanov, VP, van Bruggen, MPB, Krijnsen, HC. Device for the controlled release of a substance and method of releasing substance, US20090099553A1, 2009.
Xu, H, Wang, C, Wang, C, Zoval, J, Madou, M. Polymer actuator valves toward controlled drug delivery application. Biosens Bioelectron 2006; 21: 2094–2099.
Wood, K, Zacharia, N, Cunningham, PH, Delongchamp, D. Electronically‐degradable layer‐by‐layer thin films, US20090088679A1, 2009.
Santini, JT Jr, Richards, AC, Scheidt, R, Cima, MJ, Langer, R. Microchips as implantable drug delivery devices. Angew Chem Int Ed Engl 2000; 39: 2396–2407.
Razzacki, SZ. Integrated microsystems for controlled drug delivery. Adv Drug Deliv Rev 2004; 56: 185–198.
Grayson, ACR, Shawgo, RS, Li, Y, Cima, MJ. Electronic MEMS for triggered delivery. Adv Drug Deliv Rev 2003; 56: 173–184.
Ge, D, Tian, X, Qi, R, Huang, S, Mu, J, et al. A polypyrrole‐based microchip for controlled drug release. Electrochim Acta 2009; 55: 271–275.
d`Alarcao, M, Calias, P. Electrochemically degradable polymers, US20090024074A1, 2009.
Gravesen, P, Branebjerg, J, Jensen, OS. Micro Fluidics—a review. J Micromech Microeng 1993; 3: 168–182.
Shoji, S, Esashi, M. Microflow devices and systems. J Micromech Microeng 1994; 4: 157–171.
Sato, S, Ebert, CD, Kim, SW. Prevention of insulin self‐association and surface adsorption. J Pharm Sci 1983; 72: 228–232.
Brennan, JR, Gebhart, SS, Blackard, WG. Pump‐induced insulin aggregation. A problem with the Biostator. Diabetes 1985; 34: 353–359.
der Veen, ME, van Iersel, DG, van der Goot, AJ, Boom, RM. Shear‐induced inactivation of alpha‐amylase in a plain shear field. Biotechnol Prog 2004; 20: 1140–1145.
Amirouche, F, Zhou, Y, Johnson, T. Current micropump technologies and their biomedical applications. Microsys Tech 2009; 15: 647–666.
White, NM. The origins and the future of microfluidics. Nature 2006; 442: 368–373.
Smits, JG. Piezoelectric micropump with three valves working peristaltically. Sens Actuators 1990; A21–A23: 203–206.
Reynaerts, D, Peirs, J, Brussel, HV. An implantable drug delivery system based on shape memory alloy micro‐actuation. Sens Actuators A Phys 1997; 61: 455–462.
Benard, WL, Kahn, HA, Heuer, H, Huff, MA. Thin film shape memory alloy actuated micropumps. J Microelectromech Syst 1998; 7: 245–251.
Chen, L, Choo, J, Yan, B. The microfabricated electrokinetic pump: a potential promising drug delivery technique. Exp Opin Drug Deliv 2007; 4: 119–129.
Debiotech products page. Available at: http://www. debiotech.com/products/msys/mip.html. (Accessed January 2, 2010).
Sangkwon, N, Ridgeway, S, Cao, L. Theoretical and experimental study of fluid behavior of a peristaltic micropump. Proceedings of 15th Biennial University/Government/Industry Microelectronics Symposium, Boise State University, Boise, Idaho, 2003; 312–316.
Cao, L, Mantell, LS, Polla, D. Design and simulation of an implantable medical drug delivery system using microelectromechanical systems technology. Sens Actuators A Phys 2001; 94: 117–125.
Fiering, J, Mescher, M. Drug delivery apparatus, US20080009836A1, 2008.
Prescott, JH, Lipka, S, Baldwin, S, Sheppard, NF Jr, Maloney, JM, et al. Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device. Nat Biotechnol 2006; 24: 437–438.
Prescott, JH, Krieger, TJ, Lipka, S, Staples, MA. Dosage form development, in vitro release kinetics, and in vitro–in vivo correlation for leuprolide released from an implantable multi‐reservoir array. Pharm Res 2007; 24: 1252–1261.
Petersen, KE. Silicon as a mechanical material. Proc IEEE 1982; 70: 420–457.
Bhushan, B, Burton, Z. Adhesion and friction properties of polymers in microfluidic devices. Nanotechnology 2005; 16: 467.478.
Guse, C, Koennings, S, Blunk, T, Siepmann, J, Goepferich, A. Programmable implants‐from pulsatile to controlled release. Int J Pharm 2006; 314: 161–169.
Haykin, S. Neural Networks: A Comprehensive Foundation. New York: Prentice Hall; 1998.
Ahmed, FE. Artificial neural networks for diagnosis and survival prediction in colon cancer. Mol Cancer 2005; 4: 29.
Achanta, AS, Kowalski, JG, Rhodes, CT. Artificial neural networks: implications for pharmaceutical sciences. Drug Dev Ind Pharm 1995; 21: 119–155.
Agatonovic‐Kustrin, S, Beresford, R. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. J Pharm Biomed 2000; 22: 717–727.
Zdeblick, MJ, Robertson, T. Medical diagnostic and treatment platform using near‐field wireless communication of information within a patient`s body, US20080306359A1, 2008.
Zdeblick, MJ, Thompson, A, Pikelny, A, Robertson, T. Pharma‐informatics system, US20080284599A1, 2008.
Smith, S, Tang, TB, Stevenson, JTM, Flynn, BW, Reekie, HM, et al. Miniaturized drug delivery system with wireless power transfer and communication. IET Nanobiotechnol 2007; 1: 80–86.
U.S. Food and Drug Administration. Draft Guidance for Industry and FDA Staff Radio‐Frequency Wireless Technology in Medical Devices. Draft released for comment on January 3, 2007. Available at: http://www.fda.gov/downloads/MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/ ucm077272.pdf. (Accessed May 1, 2010).
Sheppard, N, Santini, JT Jr, Cima, MJ, Langer, RS, Ausiello, D. Method for wirelessly monitoring implanted medical device, US20080221555A1, 2008.
de Avila, J. Your iPhone just called: your blood‐sugar is high. Wall St J (East Ed) December 21, 2009; D1–D2.
Bequette, BW. A critical assessment of algorithms and challenges in the development of a closed‐loop artificial pancreas. Diabetes Technol Ther 2005; 7: 28–47.
Tang, TB, Smith, S, Flynn, BW, Stevenson, JTM, Gundlach, AM, et al. Implementation of wireless power transfer and communications for an implantable ocular drug delivery system. IET Nanobiotechnol 2008; 2: 72–79.
Santini, JT Jr, Ausiello, D. Pre‐clinical animal testing method, US20080083041A1, 2008.
Smith, S, Tang, TB, Terry, JG, Stevenson, JTM, Flynn, BW, et al. Development of a miniaturised drug delivery system with wireless power transfer and communication. IET Nanobiotechnol 2007; 1: 80–86.
Coppeta, JR, Uhland, SA, Polito, BF, Sheppard, NF Jr, Feakes, CM, et al. Hermetically sealed devices for controlled release or exposure of reservoir contents, US20070036835A1, 2007.
Daniel, K, Duc, HLH, Cima, MJ, Langer, RS. Controlled release microchips, Chapter 9. In: Youan, B‐BC, ed. Chronopharmaceutics. New York: John Wiley %26 Sons; 2009; 187–215.
Sharma, S, Nijdam, AJ, Sinha, PM, Walczak, RJ, Liu, X, et al. Controlled‐release microchips. Exp Opin Drug Deliv 2006; 3: 379–394.
Huang, W‐C, Hu, S‐H, Liu, K‐H, Chen, S‐Y, Liu, D‐M. A flexible drug delivery chip for the magnetically‐controlled release of anti‐epileptic drugs. J Controlled Release 2009; 139: 221–228.
Intra, J, Glasgow, JM, Mai, HQ, Salem, AK. Pulsatile release of biomolecules from polydimethylsiloxane (PDMS) chips with hydrolytically degradable seals. J Controlled Release 2008; 127: 280–287.
Kim, GY, Tyler, BM, Tupper, MM, Karp, JM, Langer, RS, et al. Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model. J Controlled Release 2007; 123: 172–178.
Richards, AC, Santini, JT Jr, Cima, MJ, Langer, RS. Multi‐reservoir device for controlled drug delivery, US20060189963A1, 2006.
Shawgo, RS, Grayson, ACR, Li, Y, Cima, MJ. BioMEMS for drug delivery. Curr Opin Solid State 2002; 6: 329–334.
Li, Y, Shawgo, RS, Tyler, BM, Henderson, PT, Vogel, JS, et al. In vivo release from a drug delivery MEMS device. J Controlled Release 2004; 100: 211–219.
Li, Y, Duc, HLH, Tyler, BM, Williams, T, Tupper, M, et al. In vivo delivery of BCNU from a MEMS device to a tumor model. J Controlled Release 2005; 106: 138–145.
Chung, A, Kim, D, Erickson, D. Electrokinetic microfluidic devices for rapid, low power drug delivery in autonomous microsystems. Lab Chip 2008; 8: 330–338.
Maloney, JM, Uhland, SA, Polito, BF, Sheppard, NF Jr, Pelta, CM, et al. Electrothermally activated microchips for implantable drug delivery and biosensing. J Controlled Release 2005; 109: 244–255.
Uhland, SA, Polito, B, Maloney, JM, Sheppard, NF, Herman, SJ, et al. Method for making device for controlled reservoir opening by electrothermal ablation, US20080168921A1, 2008.
Santini, JT Jr, Cima, MJ, Langer, RS. Method for operating microchip reservoir device. US20080051766A1, 2008.
Johnson, AM, Cima, MJ, Langer, RS. Microscale lyophilization and drying methods for the stabilization of molecules, US007354597B2, 2008.
Proos, ER, Prescott, JH, Staples, MA. Long‐term stability and in vitro release of hPTH(1–34) from a multi‐reservoir array. Pharm Res 2008; 25: 1387–1395.
Prescott, JH, Krieger, T, Proos, ER. Control of drug release by transient modification of local microenvironments, US007488316B2, 2009.
Ausiello, D, Santini, JT Jr, Herman, SJ, Prescott, JH, Uhland, SA, et al. Implantable device for controlled, extended delivery of parathyroid hormone, US20090163895A1, 2009.
Ausiello, D, Santini, JT Jr, Herman, SJ, Prescott, JH. Method and device for the controlled delivery of parathyroid hormone, US20040082937A1, 2004.
Liu, X, Pettway, GJ, McCauley, LK, Ma, PX. Pulsatile release of parathyroid hormone from an implantable delivery system. Biomaterials 2007; 28: 4124–4131.
Santini, JT Jr, Hutchinson, CE, Proos, ER. Medical and dental implant devices for controlled drug delivery, US20070016163A1, 2007.
Martinson, JB, Stark, JG, Hanson, TJB, Backes, SJ. Instrumented orthopedic and other medical implants, US20060271112A1, 2006.
Santini, JT Jr, Cima, MJ, Langer, RS, Ausiello, D, Sheppard, NF. Method of opening reservoir of containment device, US20080221557A1, 2008.
Santini, JT Jr, Cima, MJ, Langer, RS, Ausiello, D, Sheppard, NF. Method of actuating implanted medical device. US20080071252A1, 2008.
Sugiura, S, Sumaru, K, Ohi, K, Hiroki, K, Takagi, T, et al. Photoresponsive polymer gel microvalves controlled by local light irradiation. Sens Actuators, A 2007; 140: 176–184.
Johnson, MT, Kurt, R. Device for the controlled release of a predefined quantity of a substance, US20080208174A1, 2008.
Langer, R. Drugs on target. Science 2001; 293: 58–59.
Traitel, T, Goldbart, R, Kost, J. Smart polymers for responsive drug‐delivery systems. J Biomater Sci Polym Ed 2008; 19: 755–767.
Satarkar, NS, Hilt, JZ. Magnetic hydrogel nanocomposites for remote controlled pulsatile drug release. J Controlled Release 2008; 130: 246–251.
Yoshida, R, Sakai, T, Hara, Y, Maeda, S, Hashimoto, S, et al. Self oscillating gel as novel biomimetic materials. J Controlled Release 2009; 140: 186–193.
Yoshida, R. Design of functional polymer gels and their application to biomimetic materials. Curr Org Chem 2005; 9: 1617–1641.
Okano, T, ed. Biorelated Polymers and Gels: Controlled Release and Applications in Biomedical Engineering. London: Academic Press; 1998.
Peppas, NA, Hilt, JZ, Khademhosseini, A, Langer, R. Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv Mater (Weinheim, Ger) 2006; 18: 1345–1360.
Jun, SB, Hynd, MR, Dowell‐Mesfin, NM, Al‐Kofahi, Y, Roysam, B, et al. Modulation of cultured neural networks using neurotrophin release from hydrogel‐coated microelectrode arrays. J Neural Eng 2008; 5: 203–213.
Kikuchi, A, Okano, T. Pulsatile drug release control using hydrogels. Adv Drug Deliv Rev 2002; 54: 53–77.
Kataoka, K, Miyazaki, H, Bunya, M, Okano, T, Sakurai, Y. Totally synthetic polymer gels responding to external glucose concentration: their preparation and application to on‐off regulation of insulin release. J Am Chem Soc 1998; 120: 12694–12695.
Matsumoto, A, Yoshida, R, Kataoka, K. Glucose‐responsive polymer gel bearing phenylborate derivative as a glucose‐sensing moiety operating at the physiological pH. Biomacromolecules 2004; 5: 1038–1045.
Hoffman, AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev 2002; 43: 3–12.
Miyata, T, Uragami, T, Nakamae, K. Biomolecule‐sensitive hydrogels. Adv Drug Deliv Rev 2002; 54: 79–98.
Kiser, PF, Wilson, G, Needham, D. A synthetic mimic of the secretory granule for drug delivery. Nature 1998; 394: 459–462.
Yeghiazarian, LL, Wiesner, U, Montemagno, CD. Volume phase transition to induce gel movement, US007313917B2, 2008.
Phyllis Gardner, P. Microfabricated nanochannel implantable drug delivery devices: trends, limitations and possibilities. Adv Drug Deliv Rev 2006; 3: 479–487.
Randall, CL, Leong, TG, Bassik, N, Gracias, DH. 3D lithographically fabricated nanoliter containers for drug delivery. Adv Drug Deliv Rev 2007; 59: 1547–1561.
Boston Scientific Corporation. Form 10‐K. Annual Report for the fiscal year ended December 31, 2004. Available at: http://phx.corporate‐ir.net/phoenix.zhtml?c = 62272%26p = irol‐sec%26secCat01Enhanced.1_rs = 11%26secCat01Enhanced.1_rc = 10%26control_selectgroup = Annual%20Filings. (Accessed May 1, 2010).
Pfizer Inc. 2007 Financial Report. Available at: http://media.pfizer.com/files/annualreport/2007/financial/financial2007.pdf. (Accessed May 1, 2010).
Bayer, AG. Bayer Annual Report 2006. Available at: http://www.bayer.com/en/GB‐2006‐en.pdfx. (Accessed May 1, 2010).
Vyteris, Inc. Form 10‐Q Quarterly Report. Filed November 13, 2009. Available at: http://investor.vyteris.com/. (Accessed May 1, 2010).
Alaeea, M, Moghadama, SH, Sayyara, P, Atyabia, F, Dinarvanda, R. Preparation of a reservoir type levonorgestrel delivery system using high molecular weight poly L‐lactide. Iran J Pharm Res 2009; 8: 87–93.